Enveda Biosciences
PrivateLast Round
Series D
Sep 4, 2025
Est. Valuation
$1B
Total Funding Raised
$600.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enveda Biosciences is a biotechnology company that utilizes an AI-powered drug discovery platform to analyze natural samples for chemical structure and biological activity to develop novel small-molecule medicines.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enveda Biosciences Comparables
Compare Enveda Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insitro | 81% | |
| LifeMine Therapeutics | 79% | |
| Insilico | 79% | |
Enveda Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 4, 2025 | ||||
| Series C Extension | Feb 26, 2025 | ||||
| Series C | Nov 21, 2024 | ||||
| Series B Extension | Jun 14, 2024 | ||||
| Series B Extension | Apr 20, 2023 | ||||
Series B | Dec 21, 2022 |
Key People
Founding team and executive leadership
Enveda Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B Extension |
| Lingotto | Series B Extension, Series D, Series C |
| Global Village | Seed, Series A |
| Wireframe Ventures | Series B, Series A, Seed, Series B Extension |
| Lingotto Innovation | Series C Extension, Series C |
| Dimension | Series D |
| JAZZ Venture Partners | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
ENV-294 is one of the lead assets in clinical trials.
- Jan 1, 2026
Named one of Fast Company's Most Innovative Companies in 2026.
Enveda Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enveda Biosciences's valuation, stock price, and market status.